Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths (original) (raw)

1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2001017. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

2. Zhong N.S., Zheng B.J., Li Y.M., Poon L.L.M., Xie Z.H., Chan K.H., Li P.H., Tan S.Y., Chang Q., Xie J.P., et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet. 2003;362:1353–1358. doi: 10.1016/S0140-6736(03)14630-2. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

3. Assiri A., McGeer A., Perl T.M., Price C.S., Al Rabeeah A.A., Cummings D.A., Alabdullatif Z.N., Assad M., Almulhim A., Makhdoom H., et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 2013;369:407–416. doi: 10.1056/NEJMoa1306742. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

4. Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y., Zhu H., Zhao W., Han Y., Qin C. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses. 2019;11:59. doi: 10.3390/v11010059. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

5. Yin Y., Wunderink R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23:130–137. doi: 10.1111/resp.13196. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

6. Paget J., Spreeuwenberg P., Charu V., Taylor R.J., Iuliano A.D., Bresee J., Simonsen L., Viboud C. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J. Glob. Health. 2019;9:020421. doi: 10.7189/jogh.09.020421. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

7. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007;357:266–281. doi: 10.1056/NEJMra070553. [PubMed] [CrossRef] [Google Scholar]

8. Pike J.W., Christakos S. Biology and Mechanisms of Action of the Vitamin D Hormone. Endocrinol. Metab. Clin. 2017;46:815–843. doi: 10.1016/j.ecl.2017.07.001. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

9. Beard J.A., Bearden A., Striker R. Vitamin D and the anti-viral state. J. Clin. Virol. 2011;50:194–200. doi: 10.1016/j.jcv.2010.12.006. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

10. Hewison M. An update on vitamin D and human immunity. Clin. Endocrinol. 2012;76:315–325. doi: 10.1111/j.1365-2265.2011.04261.x. [PubMed] [CrossRef] [Google Scholar]

11. Greiller C.L., Martineau A.R. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7:4240–4270. doi: 10.3390/nu7064240. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

12. Wei R., Christakos S. Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D. Nutrients. 2015;7:8251–8260. doi: 10.3390/nu7105392. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

13. Coussens A.K. The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease. Photochem. Photobiol. Sci. 2017;16:314–338. doi: 10.1039/c6pp00355a. [PubMed] [CrossRef] [Google Scholar]

14. Lang P.O., Aspinall R. Vitamin D Status and the Host Resistance to Infections: What It Is Currently (Not) Understood. Clin. Ther. 2017;39:930–945. doi: 10.1016/j.clinthera.2017.04.004. [PubMed] [CrossRef] [Google Scholar]

15. Gruber-Bzura B.M. Vitamin D and Influenza-Prevention or Therapy? Int. J. Mol. Sci. 2018;19:2419. doi: 10.3390/ijms19082419. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

16. Rondanelli M., Miccono A., Lamburghini S., Avanzato I., Riva A., Allegrini P., Faliva M.A., Peroni G., Nichetti M., Perna S. Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds. Evid. Based Complement. Alternat. Med. 2018;2018:5813095. doi: 10.1155/2018/5813095. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

17. Gombart A.F., Pierre A., Maggini S. A Review of Micronutrients and the Immune System-Working in Harmony to Reduce the Risk of Infection. Nutrients. 2020;12:236. doi: 10.3390/nu12010236. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

18. Schwalfenberg G.K. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol. Nutr. Food Res. 2011;55:96–108. doi: 10.1002/mnfr.201000174. [PubMed] [CrossRef] [Google Scholar]

19. Kast J.I., McFarlane A.J., Globinska A., Sokolowska M., Wawrzyniak P., Sanak M., Schwarze J., Akdis C.A., Wanke K. Respiratory syncytial virus infection influences tight junction integrity. Clin. Exp. Immunol. 2017;190:351–359. doi: 10.1111/cei.13042. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

20. Chen Y., Leng K., Lu Y., Wen L., Qi Y., Gao W., Chen H., Bai L., An X., Sun B., et al. Epidemiological features and time-series analysis of influenza incidence in urban and rural areas of Shenyang, China, 2010–2018. Epidemiol. Infect. 2020;148:e29. doi: 10.1017/S0950268820000151. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

21. Rossi G.A., Fanous H., Colin A.A. Viral strategies predisposing to respiratory bacterial superinfections. Pediatr. Pulmonol. 2020 doi: 10.1002/ppul.24699. [PubMed] [CrossRef] [Google Scholar]

22. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773. doi: 10.1126/science.1123933. [PubMed] [CrossRef] [Google Scholar]

23. Adams J.S., Ren S., Liu P.T., Chun R.F., Lagishetty V., Gombart A.F., Borregaard N., Modlin R.L., Hewison M. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol. 2009;182:4289–4295. doi: 10.4049/jimmunol.0803736. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

24. Laaksi I. Vitamin D and respiratory infection in adults. Proc. Nutr. Soc. 2012;71:90–97. doi: 10.1017/S0029665111003351. [PubMed] [CrossRef] [Google Scholar]

25. Herr C., Shaykhiev R., Bals R. The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin. Biol. Ther. 2007;7:1449–1461. doi: 10.1517/14712598.7.9.1449. [PubMed] [CrossRef] [Google Scholar]

26. Agier J., Efenberger M., Brzezinska-Blaszczyk E. Cathelicidin impact on inflammatory cells. Cent. Eur. J. Immunol. 2015;40:225–235. doi: 10.5114/ceji.2015.51359. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

27. Barlow P.G., Svoboda P., Mackellar A., Nash A.A., York I.A., Pohl J., Davidson D.J., Donis R.O. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS ONE. 2011;6:e25333. doi: 10.1371/journal.pone.0025333. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

28. Zhao Y., Ran Z., Jiang Q., Hu N., Yu B., Zhu L., Shen L., Zhang S., Chen L., Chen H., et al. Vitamin D Alleviates Rotavirus Infection through a Microrna-155-5p Mediated Regulation of the TBK1/IRF3 Signaling Pathway In Vivo and In Vitro. Int. J. Mol. Sci. 2019;20 doi: 10.3390/ijms20143562. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

29. Martinez-Moreno J., Hernandez J.C., Urcuqui-Inchima S. Effect of high doses of vitamin D supplementation on dengue virus replication, Toll-like receptor expression, and cytokine profiles on dendritic cells. Mol. Cell. Biochem. 2020;464:169–180. doi: 10.1007/s11010-019-03658-w. [PubMed] [CrossRef] [Google Scholar]

30. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 doi: 10.1016/S0140-6736(20)30183-5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

31. Sharifi A., Vahedi H., Nedjat S., Rafiei H., Hosseinzadeh-Attar M.J. Effect of single-dose injection of vitamin D on immune cytokines in ulcerative colitis patients: A randomized placebo-controlled trial. APMIS. 2019;127:681–687. doi: 10.1111/apm.12982. [PubMed] [CrossRef] [Google Scholar]

32. Cantorna M.T. Mechanisms underlying the effect of vitamin D on the immune system. Proc. Nutr. Soc. 2010;69:286–289. doi: 10.1017/S0029665110001722. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

33. Lemire J.M., Adams J.S., Kermani-Arab V., Bakke A.C., Sakai R., Jordan S.C. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J. Immunol. 1985;134:3032–3035. [PubMed] [Google Scholar]

34. Cantorna M.T., Snyder L., Lin Y.D., Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015;7:3011–3021. doi: 10.3390/nu7043011. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

35. Jeffery L.E., Burke F., Mura M., Zheng Y., Qureshi O.S., Hewison M., Walker L.S., Lammas D.A., Raza K., Sansom D.M. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 2009;183:5458–5467. doi: 10.4049/jimmunol.0803217. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

36. Vasarhelyi B., Satori A., Olajos F., Szabo A., Beko G. Low vitamin D levels among patients at Semmelweis University: Retrospective analysis during a one-year period. Orv. Hetil. 2011;152:1272–1277. doi: 10.1556/OH.2011.29187. [PubMed] [CrossRef] [Google Scholar]

37. Novel C.P.E.R.E. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:145–151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. [PubMed] [CrossRef] [Google Scholar]

38. MacLaughlin J., Holick M.F. Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Invest. 1985;76:1536–1538. doi: 10.1172/JCI112134. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

39. Grober U., Kisters K. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinol. 2012;4:158–166. doi: 10.4161/derm.20731. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

40. Lei G.S., Zhang C., Cheng B.H., Lee C.H. Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia. Antimicrob. Agents Chemother. 2017;61 doi: 10.1128/AAC.01226-17. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

41. Mousavi S., Bereswill S., Heimesaat M.M. Immunomodulatory and Antimicrobial Effects of Vitamin C. Eur. J. Microbiol. Immunol. 2019;9:73–79. doi: 10.1556/1886.2019.00016. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

42. Colunga Biancatelli R.M.L., Berrill M., Marik P.E. The antiviral properties of vitamin C. Expert Rev. Anti Infect. Ther. 2020;18:99–101. doi: 10.1080/14787210.2020.1706483. [PubMed] [CrossRef] [Google Scholar]

43. Wimalawansa S.J. Global epidemic of coronavirus--COVID-19: What we can do to minimze risksl. Eur. J. Biomed. Pharm. Sci. 2020;7:432–438. [Google Scholar]

44. Kalil A.C., Thomas P.G. Influenza virus-related critical illness: Pathophysiology and epidemiology. Crit. Care. 2019;23:258. doi: 10.1186/s13054-019-2539-x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

45. Hope-Simpson R.E. The role of season in the epidemiology of influenza. J. Hyg. 1981;86:35–47. doi: 10.1017/S0022172400068728. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

46. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., Giovannucci E. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006;134:1129–1140. doi: 10.1017/S0950268806007175. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

47. Cannell J.J., Zasloff M., Garland C.F., Scragg R., Giovannucci E. On the epidemiology of influenza. Virol. J. 2008;5:29. doi: 10.1186/1743-422X-5-29. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

48. Kroll M.H., Bi C., Garber C.C., Kaufman H.W., Liu D., Caston-Balderrama A., Zhang K., Clarke N., Xie M., Reitz R.E., et al. Temporal relationship between vitamin D status and parathyroid hormone in the United States. PLoS ONE. 2015;10:e0118108. doi: 10.1371/journal.pone.0118108. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

49. Lowen A.C., Mubareka S., Steel J., Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 2007;3:1470–1476. doi: 10.1371/journal.ppat.0030151. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

50. Shaman J., Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. Proc. Natl. Acad. Sci. USA. 2009;106:3243–3248. doi: 10.1073/pnas.0806852106. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

51. Shaman J., Pitzer V.E., Viboud C., Grenfell B.T., Lipsitch M. Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol. 2010;8:e1000316. doi: 10.1371/annotation/35686514-b7a9-4f65-9663-7baefc0d63c0. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

52. Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 2010;91:1255–1260. doi: 10.3945/ajcn.2009.29094. [PubMed] [CrossRef] [Google Scholar]

53. Zhou J., Du J., Huang L., Wang Y., Shi Y., Lin H. Preventive Effects of Vitamin D on Seasonal Influenza A in Infants: A Multicenter, Randomized, Open, Controlled Clinical Trial. Pediatr. Infect. Dis. J. 2018;37:749–754. doi: 10.1097/INF.0000000000001890. [PubMed] [CrossRef] [Google Scholar]

54. Urashima M., Mezawa H., Noya M., Camargo C.A., Jr. Effects of vitamin D supplements on influenza A illness during the 2009 H1N1 pandemic: A randomized controlled trial. Food Funct. 2014;5:2365–2370. doi: 10.1039/C4FO00371C. [PubMed] [CrossRef] [Google Scholar]

55. Arihiro S., Nakashima A., Matsuoka M., Suto S., Uchiyama K., Kato T., Mitobe J., Komoike N., Itagaki M., Miyakawa Y., et al. Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2019;25:1088–1095. doi: 10.1093/ibd/izy346. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

56. Loeb M., Dang A.D., Thiem V.D., Thanabalan V., Wang B., Nguyen N.B., Tran H.T.M., Luong T.M., Singh P., Smieja M., et al. Effect of Vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: A randomized controlled trial. Influenza Other Respir. Viruses. 2019;13:176–183. doi: 10.1111/irv.12615. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

57. Sabetta J.R., DePetrillo P., Cipriani R.J., Smardin J., Burns L.A., Landry M.L. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE. 2010;5:e11088. doi: 10.1371/journal.pone.0011088. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

58. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

59. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020 doi: 10.1016/S0140-6736(20)30566-3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

60. He Q., Gu Y., Zhang M. Spatiotemporal trends of PM2.5 concentrations in central China from 2003 to 2018 based on MAIAC-derived high-resolution data. Environ. Int. 2020;137:105536. doi: 10.1016/j.envint.2020.105536. [PubMed] [CrossRef] [Google Scholar]

61. Longhin E., Holme J.A., Gualtieri M., Camatini M., Ovrevik J. Milan winter fine particulate matter (wPM2.5) induces IL-6 and IL-8 synthesis in human bronchial BEAS-2B cells, but specifically impairs IL-8 release. Toxicol. In Vitro. 2018;52:365–373. doi: 10.1016/j.tiv.2018.07.016. [PubMed] [CrossRef] [Google Scholar]

62. Autier P., Mullie P., Macacu A., Dragomir M., Boniol M., Coppens K., Pizot C., Boniol M. Effect of vitamin D supplementation on non-skeletal disorders: A systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5:986–1004. doi: 10.1016/S2213-8587(17)30357-1. [PubMed] [CrossRef] [Google Scholar]

63. Rejnmark L., Bislev L.S., Cashman K.D., Eiriksdottir G., Gaksch M., Grubler M., Grimnes G., Gudnason V., Lips P., Pilz S., et al. Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS ONE. 2017;12:e0180512. doi: 10.1371/journal.pone.0180512. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

64. Heaney R.P. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr. Rev. 2014;72:48–54. doi: 10.1111/nure.12090. [PubMed] [CrossRef] [Google Scholar]

65. Grant W.B., Boucher B.J., Bhattoa H.P., Lahore H. Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations. J. Steroid Biochem. Mol. Biol. 2018;177:266–269. doi: 10.1016/j.jsbmb.2017.08.009. [PubMed] [CrossRef] [Google Scholar]

66. Manson J.E., Cook N.R., Lee I.M., Christen W., Bassuk S.S., Mora S., Gibson H., Gordon D., Copeland T., D’Agostino D., et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N. Engl. J. Med. 2019;380:33–44. doi: 10.1056/NEJMoa1809944. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

67. Pittas A.G., Dawson-Hughes B., Sheehan P., Ware J.H., Knowler W.C., Aroda V.R., Brodsky I., Ceglia L., Chadha C., Chatterjee R., et al. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N. Engl. J. Med. 2019;381:520–530. doi: 10.1056/NEJMoa1900906. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

68. Lu D., Zhang J., Ma C., Yue Y., Zou Z., Yu C., Yin F. Link between community-acquired pneumonia and vitamin D levels in older patients. Z. Gerontol. Geriatr. 2018;51:435–439. doi: 10.1007/s00391-017-1237-z. [PubMed] [CrossRef] [Google Scholar]

69. Zhou Y.F., Luo B.A., Qin L.L. The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies. Medicine. 2019;98:e17252. doi: 10.1097/MD.0000000000017252. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

70. Manion M., Hullsiek K.H., Wilson E.M.P., Rhame F., Kojic E., Gibson D., Hammer J., Patel P., Brooks J.T., Baker J.V., et al. Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons. PLoS ONE. 2017;12:e0175517. doi: 10.1371/journal.pone.0175517. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

71. Dalvi S.M., Ramraje N.N., Patil V.W., Hegde R., Yeram N. Study of IL-6 and vitamin D3 in patients of pulmonary tuberculosis. Indian J. Tuberc. 2019;66:337–345. doi: 10.1016/j.ijtb.2018.05.018. [PubMed] [CrossRef] [Google Scholar]

72. Poudel-Tandukar K., Poudel K.C., Jimba M., Kobayashi J., Johnson C.A., Palmer P.H. Serum 25-hydroxyvitamin d levels and C-reactive protein in persons with human immunodeficiency virus infection. AIDS Res. Hum. Retrovir. 2013;29:528–534. doi: 10.1089/aid.2012.0120. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

73. Zhang M., Gao Y., Tian L., Zheng L., Wang X., Liu W., Zhang Y., Huang G. Association of serum 25-hydroxyvitamin D3 with adipokines and inflammatory marker in persons with prediabetes mellitus. Clin. Chim. Acta. 2017;468:152–158. doi: 10.1016/j.cca.2017.02.022. [PubMed] [CrossRef] [Google Scholar]

74. Zhou W., Mao S., Wu L., Yu J. Association Between Vitamin D Status and Sepsis. Clin. Lab. 2018;64:451–460. doi: 10.7754/Clin.Lab.2017.170919. [PubMed] [CrossRef] [Google Scholar]

75. Li Y., Ding S. Serum 25-Hydroxyvitamin D and the risk of mortality in adult patients with Sepsis: A meta-analysis. BMC Infect. Dis. 2020;20:189. doi: 10.1186/s12879-020-4879-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

76. Thickett D.R., Moromizato T., Litonjua A.A., Amrein K., Quraishi S.A., Lee-Sarwar K.A., Mogensen K.M., Purtle S.W., Gibbons F.K., Camargo C.A., Jr., et al. Association between prehospital vitamin D status and incident acute respiratory failure in critically ill patients: A retrospective cohort study. BMJ Open Respir. Res. 2015;2:e000074. doi: 10.1136/bmjresp-2014-000074. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

77. Dancer R.C., Parekh D., Lax S., D’Souza V., Zheng S., Bassford C.R., Park D., Bartis D.G., Mahida R., Turner A.M., et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS) Thorax. 2015;70:617–624. doi: 10.1136/thoraxjnl-2014-206680. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

78. Hou Y.M., Zhao J.Y., Liu H.Y. Impact of serum 25-hydroxyvitamin D on cardiac prognosis in Chinese patients with heart failure. Br. J. Nutr. 2019;122:162–171. doi: 10.1017/S0007114519000795. [PubMed] [CrossRef] [Google Scholar]

79. Aparicio-Ugarriza R., Salguero D., Mohammed Y.N., Ferri-Guerra J., Baskaran D.J., Mirabbasi S.A., Rodriguez A., Ruiz J.G. Is vitamin D deficiency related to a higher risk of hospitalization and mortality in veterans with heart failure? Maturitas. 2020;132:30–34. doi: 10.1016/j.maturitas.2019.11.005. [PubMed] [CrossRef] [Google Scholar]

80. McDonnell S.L., Baggerly L.L., French C.B., Heaney R.P., Gorham E.D., Holick M.F., Scragg R., Garland C.F. Incidence rate of type 2 diabetes is >50% lower in GrassrootsHealth cohort with median serum 25-hydroxyvitamin D of 41 ng/mL than in NHANES cohort with median of 22 ng/mL. J. Steroid Biochem. Mol. Biol. 2016;155:239–244. doi: 10.1016/j.jsbmb.2015.06.013. [PubMed] [CrossRef] [Google Scholar]

81. Xie Z., Xia W., Zhang Z., Wu W., Lu C., Tao S., Wu L., Gu J., Chandler J., Peter S., et al. Prevalence of Vitamin D Inadequacy Among Chinese Postmenopausal Women: A Nationwide, Multicenter, Cross-Sectional Study. Front. Endocrinol. 2019;9:782. doi: 10.3389/fendo.2018.00782. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

82. Brot C., Jorgensen N.R., Sorensen O.H. The influence of smoking on vitamin D status and calcium metabolism. Eur. J. Clin. Nutr. 1999;53:920–926. doi: 10.1038/sj.ejcn.1600870. [PubMed] [CrossRef] [Google Scholar]

83. Pilz S., Marz W., Cashman K.D., Kiely M.E., Whiting S.J., Holick M.F., Grant W.B., Pludowski P., Hiligsmann M., Trummer C., et al. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper. Front. Endocrinol. 2018;9:373. doi: 10.3389/fendo.2018.00373. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

84. Chen X., Wu W., Wang L., Shi Y., Shen F., Gu X., Jia Z. Association Between 25-Hydroxyvitamin D and Epicardial Adipose Tissue in Chinese Non-Obese Patients with Type 2 Diabetes. Med. Sci. Monit. 2017;23:4304–4311. doi: 10.12659/MSM.904755. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

85. Lucato P., Solmi M., Maggi S., Bertocco A., Bano G., Trevisan C., Manzato E., Sergi G., Schofield P., Kouidrat Y., et al. Low vitamin D levels increase the risk of type 2 diabetes in older adults: A systematic review and meta-analysis. Maturitas. 2017;100:8–15. doi: 10.1016/j.maturitas.2017.02.016. [PubMed] [CrossRef] [Google Scholar]

86. Qi D., Nie X.L., Wu S., Cai J. Vitamin D and hypertension: Prospective study and meta-analysis. PLoS ONE. 2017;12:e0174298. doi: 10.1371/journal.pone.0174298. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

87. Gholami F., Moradi G., Zareei B., Rasouli M.A., Nikkhoo B., Roshani D., Ghaderi E. The association between circulating 25-hydroxyvitamin D and cardiovascular diseases: A meta-analysis of prospective cohort studies. BMC Cardiovasc. Disord. 2019;19:248. doi: 10.1186/s12872-019-1236-7. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

88. Zhu M., Wang T., Wang C., Ji Y. The association between vitamin D and COPD risk, severity, and exacerbation: An updated systematic review and meta-analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 2016;11:2597–2607. doi: 10.2147/COPD.S101382. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

89. Hoseinzadeh E., Taha P., Wei C., Godini H., Ashraf G.M., Taghavi M., Miri M. The impact of air pollutants, UV exposure and geographic location on vitamin D deficiency. Food Chem. Toxicol. 2018;113:241–254. doi: 10.1016/j.fct.2018.01.052. [PubMed] [CrossRef] [Google Scholar]

90. Slow S., Epton M., Storer M., Thiessen R., Lim S., Wong J., Chin P., Tovaranonte P., Pearson J., Chambers S.T., et al. Effect of adjunctive single high-dose vitamin D3 on outcome of community-acquired pneumonia in hospitalised adults: The VIDCAPS randomised controlled trial. Sci. Rep. 2018;8:13829. doi: 10.1038/s41598-018-32162-2. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

91. Mirzavandi F., Talenezhad N., Razmpoosh E., Nadjarzadeh A., Mozaffari-Khosravi H. The effect of intramuscular megadose of vitamin D injections on E-selectin, CRP and biochemical parameters in vitamin D-deficient patients with type-2 diabetes mellitus: A randomized controlled trial. Complement. Ther. Med. 2020;49:102346. doi: 10.1016/j.ctim.2020.102346. [PubMed] [CrossRef] [Google Scholar]

92. Amrein K., Papinutti A., Mathew E., Vila G., Parekh D. Vitamin D and critical illness: What endocrinology can learn from intensive care and vice versa. Endocr. Connect. 2018;7:R304–R315. doi: 10.1530/EC-18-0184. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

93. Han J.E., Jones J.L., Tangpricha V., Brown M.A., Brown L.A.S., Hao L., Hebbar G., Lee M.J., Liu S., Ziegler T.R., et al. High Dose Vitamin D Administration in Ventilated Intensive Care Unit Patients: A Pilot Double Blind Randomized Controlled Trial. J. Clin. Transl. Endocrinol. 2016;4:59–65. doi: 10.1016/j.jcte.2016.04.004. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

94. Cho N.H., Shaw J.E., Karuranga S., Huang Y., da Rocha Fernandes J.D., Ohlrogge A.W., Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018;138:271–281. doi: 10.1016/j.diabres.2018.02.023. [PubMed] [CrossRef] [Google Scholar]

95. Henley S.J., Gallaway S., Singh S.D., O’Neil M.E., Buchanan Lunsford N., Momin B., Richards T.B. Lung Cancer Among Women in the United States. J. Womens Health. 2018;27:1307–1316. doi: 10.1089/jwh.2018.7397. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

96. Malinovschi A., Masoero M., Bellocchia M., Ciuffreda A., Solidoro P., Mattei A., Mercante L., Heffler E., Rolla G., Bucca C. Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients. Respir. Res. 2014;15:131. doi: 10.1186/s12931-014-0131-0. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

97. Kim H.J., Jang J.G., Hong K.S., Park J.K., Choi E.Y. Relationship between serum vitamin D concentrations and clinical outcome of community-acquired pneumonia. Int. J. Tuberc. Lung Dis. 2015;19:729–734. doi: 10.5588/ijtld.14.0696. [PubMed] [CrossRef] [Google Scholar]

98. Naghshtabrizi B., Borzouei S., Bigvand P., Seifrabiei M.A. Evaluation of the Relationship between Serum 25-Hydroxy Vitamin D and Hypertension in Hamadan, Iran-A Case Control Study. J. Clin. Diagn. Res. 2017;11:LC01–LC03. doi: 10.7860/JCDR/2017/25522.10187. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

99. Valcour A., Blocki F., Hawkins D.M., Rao S.D. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J. Clin. Endocrinol. Metab. 2012;97:3989–3995. doi: 10.1210/jc.2012-2276. [PubMed] [CrossRef] [Google Scholar]

100. Christensen M.H., Lien E.A., Hustad S., Almas B. Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. Scand. J. Clin. Lab. Invest. 2010;70:281–286. doi: 10.3109/00365511003797172. [PubMed] [CrossRef] [Google Scholar]

101. Nam H.H., Ison M.G. Respiratory syncytial virus infection in adults. BMJ. 2019;366:l5021. doi: 10.1136/bmj.l5021. [PubMed] [CrossRef] [Google Scholar]

102. Paynter S., Ware R.S., Sly P.D., Weinstein P., Williams G. Respiratory syncytial virus seasonality in tropical Australia. Aust. N. Z. J. Public Health. 2015;39:8–10. doi: 10.1111/1753-6405.12347. [PubMed] [CrossRef] [Google Scholar]

103. Feng X., Guo T., Wang Y., Kang D., Che X., Zhang H., Cao W., Wang P. The vitamin D status and its effects on life quality among the elderly in Jinan, China. Arch. Gerontol. Geriatr. 2016;62:26–29. doi: 10.1016/j.archger.2015.09.002. [PubMed] [CrossRef] [Google Scholar]

104. Nassar M.S., Bakhrebah M.A., Meo S.A., Alsuabeyl M.S., Zaher W.A. Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS-CoV) infection. Eur. Rev. Med. Pharmacol. Sci. 2018;22:3913–3918. doi: 10.26355/eurrev_201806_15276. [PubMed] [CrossRef] [Google Scholar]

105. Grant W.B., Fakhoury H.M.A., Karras S.N., Al Anouti F., Bhattoa H.P. Variations in 25-Hydroxyvitamin D in Countries from the Middle East and Europe: The Roles of UVB Exposure and Diet. Nutrients. 2019;11:2065. doi: 10.3390/nu11092065. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

106. Moura F.E., Perdigao A.C., Siqueira M.M. Seasonality of influenza in the tropics: A distinct pattern in northeastern Brazil. Am. J. Trop. Med. Hyg. 2009;81:180–183. doi: 10.4269/ajtmh.2009.81.180. [PubMed] [CrossRef] [Google Scholar]

107. Arboleda J.F., Urcuqui-Inchima S. Vitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection? Adv. Virol. 2016;2016:1016840. doi: 10.1155/2016/1016840. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

108. Villamor E., Villar L.A., Lozano A., Herrera V.M., Herran O.F. Vitamin D serostatus and dengue fever progression to dengue hemorrhagic fever/dengue shock syndrome. Epidemiol. Infect. 2017;145:2961–2970. doi: 10.1017/S0950268817002059. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

109. Fan H.Z., Zhang R., Tian T., Zhong Y.L., Wu M.P., Xie C.N., Yang J.J., Huang P., Yu R.B., Zhang Y., et al. CYP24A1 genetic variants in the vitamin D metabolic pathway are involved in the outcomes of hepatitis C virus infection among high-risk Chinese population. Int. J. Infect. Dis. 2019;84:80–88. doi: 10.1016/j.ijid.2019.04.032. [PubMed] [CrossRef] [Google Scholar]

110. Hu Y.C., Wang W.W., Jiang W.Y., Li C.Q., Guo J.C., Xun Y.H. Low vitamin D levels are associated with high viral loads in patients with chronic hepatitis B: A systematic review and meta-analysis. BMC Gastroenterol. 2019;19:84. doi: 10.1186/s12876-019-1004-2. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

111. Brice D.C., Toth Z., Diamond G. LL-37 disrupts the Kaposi’s sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells. Antivir. Res. 2018;158:25–33. doi: 10.1016/j.antiviral.2018.07.025. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

112. Alvarez N., Aguilar-Jimenez W., Rugeles M.T. The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection. Front. Immunol. 2019;10:2291. doi: 10.3389/fimmu.2019.02291. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

113. Gui B., Chen Q., Hu C., Zhu C., He G. Effects of calcitriol (1, 25-dihydroxy-vitamin D3) on the inflammatory response induced by H9N2 influenza virus infection in human lung A549 epithelial cells and in mice. Virol. J. 2017;14:10. doi: 10.1186/s12985-017-0683-y. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

114. Currie S.M., Findlay E.G., McHugh B.J., Mackellar A., Man T., Macmillan D., Wang H., Fitch P.M., Schwarze J., Davidson D.J. The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS ONE. 2013;8:e73659. doi: 10.1371/journal.pone.0073659. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

115. Laplana M., Royo J.L., Fibla J. Vitamin D Receptor polymorphisms and risk of enveloped virus infection: A meta-analysis. Gene. 2018;678:384–394. doi: 10.1016/j.gene.2018.08.017. [PubMed] [CrossRef] [Google Scholar]

116. Bucak I.H., Ozturk A.B., Almis H., Cevik M.O., Tekin M., Konca C., Turgut M., Bulbul M. Is there a relationship between low vitamin D and rotaviral diarrhea? Pediatr. Int. 2016;58:270–273. doi: 10.1111/ped.12809. [PubMed] [CrossRef] [Google Scholar]

117. Theron M., Huang K.J., Chen Y.W., Liu C.C., Lei H.Y. A probable role for IFN-gamma in the development of a lung immunopathology in SARS. Cytokine. 2005;32:30–38. doi: 10.1016/j.cyto.2005.07.007. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

118. Wong C.K., Lam C.W., Wu A.K., Ip W.K., Lee N.L., Chan I.H., Lit L.C., Hui D.S., Chan M.H., Chung S.S., et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 2004;136:95–103. doi: 10.1111/j.1365-2249.2004.02415.x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

119. Mahallawi W.H., Khabour O.F., Zhang Q., Makhdoum H.M., Suliman B.A. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018;104:8–13. doi: 10.1016/j.cyto.2018.01.025. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

120. Britten R. The incidence of epidemic influenza, 1918-19. Public Health Rep. 1932;47:303–339. doi: 10.2307/4580340. [CrossRef] [Google Scholar]

121. Grant W.B., Giovannucci E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918–1919 influenza pandemic in the United States. Dermatoendocrinol. 2009;1:215–219. doi: 10.4161/derm.1.4.9063. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

122. Feigenbaum J.J., Muller C., Wrigley-Field E. Regional and Racial Inequality in Infectious Disease Mortality in U.S. Cities, 1900–1948. Demography. 2019;56:1371–1388. doi: 10.1007/s13524-019-00789-z. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

123. Aloia J.F., Li-Ng M. Re: Epidemic influenza and vitamin D. Epidemiol. Infect. 2007;135:1095–1096. doi: 10.1017/S0950268807008308. author reply 1097–1098. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

124. Ginde A.A., Liu M.C., Camargo C.A., Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch. Intern. Med. 2009;169:626–632. doi: 10.1001/archinternmed.2008.604. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

125. Clay K., Lewis J., Severnini E. What explains cross-city variation in mortality during the 1918 influenza pandemic? Evidence from 438 U.S. cities. Econ. Hum. Biol. 2019;35:42–50. doi: 10.1016/j.ehb.2019.03.010. [PubMed] [CrossRef] [Google Scholar]

126. Liu X.X., Li Y., Qin G., Zhu Y., Li X., Zhang J., Zhao K., Hu M., Wang X.L., Zheng X. Effects of air pollutants on occurrences of influenza-like illness and laboratory-confirmed influenza in Hefei, China. Int. J. Biometeorol. 2019;63:51–60. doi: 10.1007/s00484-018-1633-0. [PubMed] [CrossRef] [Google Scholar]

127. Croft D.P., Zhang W., Lin S., Thurston S.W., Hopke P.K., van Wijngaarden E., Squizzato S., Masiol M., Utell M.J., Rich D.Q. Associations between Source-Specific Particulate Matter and Respiratory Infections in New York State Adults. Environ. Sci. Technol. 2020;54:975–984. doi: 10.1021/acs.est.9b04295. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

128. Smith E.M., Jones J.L., Han J.E., Alvarez J.A., Sloan J.H., Konrad R.J., Zughaier S.M., Martin G.S., Ziegler T.R., Tangpricha V. High-Dose Vitamin D3 Administration Is Associated With Increases in Hemoglobin Concentrations in Mechanically Ventilated Critically Ill Adults: A Pilot Double-Blind, Randomized, Placebo-Controlled Trial. JPEN J. Parenter. Enter. Nutr. 2018;42:87–94. doi: 10.1177/0148607116678197. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

129. Centers for Disease Control and Prevention Update: Severe acute respiratory syndrome--Toronto, Canada, 2003. MMWR Morb. Mortal. Wkly. Rep. 2003;52:547–550. [PubMed] [Google Scholar]

130. Hagel S., Ludewig K., Moeser A., Baier M., Loffler B., Schleenvoigt B., Forstner C., Pletz M.W. Characteristics and management of patients with influenza in a German hospital during the 2014/2015 influenza season. Infection. 2016;44:667–672. doi: 10.1007/s15010-016-0920-0. [PubMed] [CrossRef] [Google Scholar]

131. Youssef D.A., Ranasinghe T., Grant W.B., Peiris A.N. Vitamin D’s potential to reduce the risk of hospital-acquired infections. Derm. Endocrinol. 2012;4:167–175. doi: 10.4161/derm.20789. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

132. Quraishi S.A., Bittner E.A., Blum L., Hutter M.M., Camargo C.A., Jr. Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following Roux-en-Y gastric bypass surgery. JAMA Surg. 2014;149:112–118. doi: 10.1001/jamasurg.2013.3176. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

133. Laviano E., Sanchez Rubio M., Gonzalez-Nicolas M.T., Palacian M.P., Lopez J., Gilaberte Y., Calmarza P., Rezusta A., Serrablo A. Association between preoperative levels of 25-hydroxyvitamin D and hospital-acquired infections after hepatobiliary surgery: A prospective study in a third-level hospital. PLoS ONE. 2020;15:e0230336. doi: 10.1371/journal.pone.0230336. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

134. Martineau A.R., Jolliffe D.A., Hooper R.L., Greenberg L., Aloia J.F., Bergman P., Dubnov-Raz G., Esposito S., Ganmaa D., Ginde A.A., et al. Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. doi: 10.1136/bmj.i6583. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

135. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 2003;77:204–210. doi: 10.1093/ajcn/77.1.204. [PubMed] [CrossRef] [Google Scholar]

136. van Groningen L., Opdenoordt S., van Sorge A., Telting D., Giesen A., de Boer H. Cholecalciferol loading dose guideline for vitamin D-deficient adults. Eur. J. Endocrinol. 2010;162:805–811. doi: 10.1530/EJE-09-0932. [PubMed] [CrossRef] [Google Scholar]

137. Amir E., Simmons C.E., Freedman O.C., Dranitsaris G., Cole D.E., Vieth R., Ooi W.S., Clemons M. A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases. Cancer. 2010;116:284–291. doi: 10.1002/cncr.24749. [PubMed] [CrossRef] [Google Scholar]

138. Charoenngam N., Shirvani A., Kalajian T.A., Song A., Holick M.F. The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in Healthy Adults: A Randomized, Double-blinded, Dose-response Study. Anticancer Res. 2020;40:551–556. doi: 10.21873/anticanres.13984. [PubMed] [CrossRef] [Google Scholar]

139. Ekwaru J.P., Zwicker J.D., Holick M.F., Giovannucci E., Veugelers P.J. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS ONE. 2014;9:e111265. doi: 10.1371/journal.pone.0111265. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

140. Shirvani A., Kalajian T.A., Song A., Holick M.F. Disassociation of Vitamin D’s Calcemic Activity and Non-calcemic Genomic Activity and Individual Responsiveness: A Randomized Controlled Double-Blind Clinical Trial. Sci. Rep. 2019;9:17685. doi: 10.1038/s41598-019-53864-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

141. McCullough P.J., Lehrer D.S., Amend J. Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience. J. Steroid Biochem. Mol. Biol. 2019;189:228–239. doi: 10.1016/j.jsbmb.2018.12.010. [PubMed] [CrossRef] [Google Scholar]

142. Holick M.F. Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 1995;61:638S–645S. doi: 10.1093/ajcn/61.3.638S. [PubMed] [CrossRef] [Google Scholar]

143. Howard J.E., Meyer R.J. Intoxication with vitamin D. J. Clin. Endocrinol. Metab. 1948;8:895–910. doi: 10.1210/jcem-8-11-895. [PubMed] [CrossRef] [Google Scholar]

144. Malihi Z., Lawes C.M.M., Wu Z., Huang Y., Waayer D., Toop L., Khaw K.T., Camargo C.A., Scragg R. Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: Results from a randomized controlled trial. Am. J. Clin. Nutr. 2019;109:1578–1587. doi: 10.1093/ajcn/nqy378. [PubMed] [CrossRef] [Google Scholar]

145. Cianferotti L., Bertoldo F., Bischoff-Ferrari H.A., Bruyere O., Cooper C., Cutolo M., Kanis J.A., Kaufman J.M., Reginster J.Y., Rizzoli R., et al. Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: Research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) Endocrine. 2017;56:245–261. doi: 10.1007/s12020-017-1290-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

146. Lappe J., Watson P., Travers-Gustafson D., Recker R., Garland C., Gorham E., Baggerly K., McDonnell S.L. Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial. JAMA. 2017;317:1234–1243. doi: 10.1001/jama.2017.2115. [PubMed] [CrossRef] [Google Scholar]

147. Amrein K., Scherkl M., Hoffmann M., Neuwersch-Sommeregger S., Kostenberger M., Tmava Berisha A., Martucci G., Pilz S., Malle O. Vitamin D deficiency 2.0: An update on the current status worldwide. Eur. J. Clin. Nutr. 2020 doi: 10.1038/s41430-020-0558-y. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

148. Grant W.B., Al Anouti F., Moukayed M. Targeted 25-hydroxyvitamin D concentration measurements and vitamin D3 supplementation can have important patient and public health benefits. Eur. J. Clin. Nutr. 2020 doi: 10.1038/s41430-020-0564-0. [PubMed] [CrossRef] [Google Scholar]

149. Garland C.F., Gorham E.D., Mohr S.B., Garland F.C. Vitamin D for cancer prevention: Global perspective. Ann. Epidemiol. 2009;19:468–483. doi: 10.1016/j.annepidem.2009.03.021. [PubMed] [CrossRef] [Google Scholar]

150. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M., Clinton S.K., Durazo-Arvizu R.A., Gallagher J.C., Gallo R.L., Jones G., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J. Clin. Endocrinol. Metab. 2011;96:53–58. doi: 10.1210/jc.2010-2704. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

151. Grant W.B., Karras S.N., Bischoff-Ferrari H.A., Annweiler C., Boucher B.J., Juzeniene A., Garland C.F., Holick M.F. Do studies reporting ‘U’-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects? Derm. Endocrinol. 2016;8:e1187349. doi: 10.1080/19381980.2016.1187349. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

152. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M., Endocrine S. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011;96:1911–1930. doi: 10.1210/jc.2011-0385. [PubMed] [CrossRef] [Google Scholar]

153. Veugelers P.J., Pham T.M., Ekwaru J.P. Optimal Vitamin D Supplementation Doses that Minimize the Risk for Both Low and High Serum 25-Hydroxyvitamin D Concentrations in the General Population. Nutrients. 2015;7:10189–10208. doi: 10.3390/nu7125527. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

154. Pludowski P., Holick M.F., Grant W.B., Konstantynowicz J., Mascarenhas M.R., Haq A., Povoroznyuk V., Balatska N., Barbosa A.P., Karonova T., et al. Vitamin D supplementation guidelines. J. Steroid Biochem. Mol. Biol. 2018;175:125–135. doi: 10.1016/j.jsbmb.2017.01.021. [PubMed] [CrossRef] [Google Scholar]

155. Grant W.B., Boucher B.J. A Review of the Potential Benefits of Increasing Vitamin D Status in Mongolian Adults through Food Fortification and Vitamin D Supplementation. Nutrients. 2019;11:2452. doi: 10.3390/nu11102452. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

156. Camargo C.A., Jr., Ganmaa D., Frazier A.L., Kirchberg F.F., Stuart J.J., Kleinman K., Sumberzul N., Rich-Edwards J.W. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012;130:e561–e567. doi: 10.1542/peds.2011-3029. [PubMed] [CrossRef] [Google Scholar]

157. Uwitonze A.M., Razzaque M.S. Role of Magnesium in Vitamin D Activation and Function. J. Am. Osteopath Assoc. 2018;118:181–189. doi: 10.7556/jaoa.2018.037. [PubMed] [CrossRef] [Google Scholar]